24658113|t|EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-beta oligomers.
24658113|a|The early stages of Alzheimer's disease are characterised by impaired synaptic plasticity and synapse loss. Here, we show that amyloid-beta oligomers (AbetaOs) activate the c-Abl kinase in dendritic spines of cultured hippocampal neurons and that c-Abl kinase activity is required for AbetaOs-induced synaptic loss. We also show that the EphA4 receptor tyrosine kinase is upstream of c-Abl activation by AbetaOs. EphA4 tyrosine phosphorylation (activation) is increased in cultured neurons and synaptoneurosomes exposed to AbetaOs, and in Alzheimer-transgenic mice brain. We do not detect c-Abl activation in EphA4-knockout neurons exposed to AbetaOs. More interestingly, we demonstrate EphA4/c-Abl activation is a key-signalling event that mediates the synaptic damage induced by AbetaOs. According to this results, the EphA4 antagonistic peptide KYL and c-Abl inhibitor STI prevented i) dendritic spine reduction, ii) the blocking of LTP induction and iii) neuronal apoptosis caused by AbetaOs. Moreover, EphA4-/- neurons or sh-EphA4-transfected neurons showed reduced synaptotoxicity by AbetaOs. Our results are consistent with EphA4 being a novel receptor that mediates synaptic damage induced by AbetaOs. EphA4/c-Abl signalling could be a relevant pathway involved in the early cognitive decline observed in Alzheimer's disease patients. 
24658113	0	5	EphA4	Gene	2043
24658113	20	25	c-Abl	Gene	25
24658113	44	48	loss	Disease	MESH:D016388
24658113	76	88	amyloid-beta	Gene	351
24658113	120	139	Alzheimer's disease	Disease	MESH:D000544
24658113	161	189	impaired synaptic plasticity	Disease	MESH:D010411
24658113	194	206	synapse loss	Disease	MESH:D016388
24658113	227	239	amyloid-beta	Gene	351
24658113	251	258	AbetaOs	Chemical	-
24658113	385	392	AbetaOs	Chemical	-
24658113	410	414	loss	Disease	MESH:D016388
24658113	438	443	EphA4	Gene	13838
24658113	444	468	receptor tyrosine kinase	Gene	22174
24658113	484	489	c-Abl	Gene	25
24658113	504	511	AbetaOs	Chemical	-
24658113	513	518	EphA4	Gene	13838
24658113	623	630	AbetaOs	Chemical	-
24658113	639	648	Alzheimer	Disease	MESH:D000544
24658113	660	664	mice	Species	10090
24658113	689	694	c-Abl	Gene	11350
24658113	709	714	EphA4	Gene	13838
24658113	743	750	AbetaOs	Chemical	-
24658113	787	792	EphA4	Gene	2043
24658113	793	798	c-Abl	Gene	25
24658113	854	869	synaptic damage	Disease	MESH:D012183
24658113	881	888	AbetaOs	Chemical	-
24658113	921	926	EphA4	Gene	2043
24658113	948	951	KYL	Chemical	-
24658113	956	961	c-Abl	Gene	11350
24658113	1059	1077	neuronal apoptosis	Disease	MESH:D065703
24658113	1088	1095	AbetaOs	Disease	MESH:C000718787
24658113	1107	1112	EphA4	Gene	2043
24658113	1130	1135	EphA4	Gene	2043
24658113	1171	1186	synaptotoxicity	Disease	
24658113	1190	1197	AbetaOs	Chemical	-
24658113	1231	1236	EphA4	Gene	2043
24658113	1274	1289	synaptic damage	Disease	MESH:D012183
24658113	1301	1308	AbetaOs	Chemical	-
24658113	1310	1315	EphA4	Gene	2043
24658113	1316	1321	c-Abl	Gene	25
24658113	1383	1400	cognitive decline	Disease	MESH:D003072
24658113	1413	1432	Alzheimer's disease	Disease	MESH:D000544
24658113	1433	1441	patients	Species	9606
24658113	Association	MESH:D016388	25
24658113	Association	MESH:D016388	2043
24658113	Association	MESH:D000544	25
24658113	Association	MESH:D012183	25
24658113	Positive_Correlation	MESH:D016388	351
24658113	Association	MESH:D003072	2043
24658113	Association	MESH:D003072	25
24658113	Association	13838	25
24658113	Association	25	351
24658113	Positive_Correlation	2043	25
24658113	Association	2043	351
24658113	Association	MESH:D065703	11350
24658113	Association	MESH:D012183	2043

